Latest Strategic Outlook News

IDT Australia announces the immediate resignation of CEO Paul McDonald, appointing Executive Chair Mark Simari to lead as the company reports a 40.6% revenue increase but a widening net loss for FY25.

360 Capital Mortgage REIT (ASX – TCF) reported a robust FY25 with a 38.4% increase in distributions and a 74.6% rise in operating profit, underpinned by a high-quality fixed-rate loan portfolio and successful capital raisings.

360 Capital Mortgage REIT (TCF) reported a robust FY25 with a 21.5% total unitholder return and significant capital raising activity that doubled its market capitalization.

Classic Minerals has completed a design study for a 250,000 tonnes per annum Carbon-in-Leach gold processing plant at Forrestania, appointing IPS Global as EPCM contractor and outlining a scalable growth strategy.

AMP Limited reported a 9.2% rise in underlying net profit after tax for the first half of 2025, alongside a declared interim dividend, while navigating fresh legal challenges.

Argent Minerals is fast-tracking its Kempfield Polymetallic Project in NSW, launching diamond drilling and metallurgical testwork to explore early production options and support a scoping study.

Siren Gold Limited has revealed promising high-grade antimony and gold mineralisation at its Langdons Project near Reefton, New Zealand, highlighting significant exploration progress in a historically mined area.

Eastern Metals has agreed to sell its Browns Reef Project tenements to Australian Gold and Copper, offering shareholders an immediate benefit and ongoing exposure through share distribution.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

D3 Energy’s latest re-test of the RBD10 well in South Africa’s ER315 permit shows a remarkable 38% increase in gas flow, underscoring unique reservoir dynamics that could lower development costs.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.

Credit Corp Group delivered a robust FY25 with a 16% increase in net profit after tax, driven by US debt buying and Australian/NZ lending growth. The company sets an ambitious FY26 outlook, underpinned by a record US investment pipeline and new product launches.